Silence Therapeutics Archives - Inside Precision Medicine

Inside Precision Medicine Lipoprotein(a) Lowering Draw Between Lilly and Silence

Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).

News & Features

Lipoprotein(a) Lowering Draw Between Lilly and Silence

November 19, 2024

Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).

Molecular Dx

siRNA Promising For Lp(a)-Driven Heart Disease

April 5, 2022

Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).

Molecular Dx

Silence Therapeutics Announces Positive Phase I Results for Lead RNA Therapeutic

February 9, 2022

Illustration of DNA helices undergoing gene or base editing on a blue background

Molecular Dx

Gene-Silencing Tool Could Help Develop Better Therapeutics for Genetic Disease

February 3, 2022

Related Content

In Vivo Gene Therapy with Apolipoprotein Nanoparticles Targets Bone Marrow

In Vivo Gene Therapy with Apolipoprotein Nanoparticles Targets Bone Marrow

Atalanta Raises $97M to Advance Two Neuro-Targeting RNAi Therapies into the Clinic

Atalanta Raises $97M to Advance Two Neuro-Targeting RNAi Therapies into the Clinic

Employers Can Add WGS to Health Benefits Through New MyOme, Novi Health Offering

Employers Can Add WGS to Health Benefits Through New MyOme, Novi Health Offering

Accelerating Drug Discovery Using the Next Generation of Humanized Immune System Mice

Accelerating Drug Discovery Using the Next Generation of Humanized Immune System Mice